Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 16;12(4):408-414.
doi: 10.1016/j.ijnss.2025.06.006. eCollection 2025 Jul.

Efficacy and safety of exercise rehabilitation in the vulnerable phase in patients with acute decompensated heart failure: A systematic review and meta-analysis

Lihua Zhao  1 , Jing Ye  1 , Zhuo Zhao  1 , Lei Yang  2 , Yimei Zheng  3
Affiliations
Review

Efficacy and safety of exercise rehabilitation in the vulnerable phase in patients with acute decompensated heart failure: A systematic review and meta-analysis

Lihua Zhao et al. Int J Nurs Sci. .

Abstract

Objectives: This study aimed to assess the impact of exercise rehabilitation during the vulnerable period on cardiac recovery (CR) outcomes in patients with acute decompensated heart failure (ADHF).

Methods: Multiple databases including PubMed, Web of Science, Embase, the Cochrane Library, CINAHL, China National Knowledge Infrastructure (CNKI), Chinese Science and Technology Periodical Database (VIP), Wanfang database, SinoMed, ClinicalTrials.gov, and American Heart Association (AHA) and European Society of Cardiology (ESC) were searched for RCTs on exercise rehabilitation in ADHF patients' vulnerable period from inception to April 2, 2025. The risk of bias was assessed with Cochrane Risk of Bias 2.0, and data were analyzed in RevMan 5.3.

Results: A total of seven RCTs involving 946 patients were included. The results demonstrated that exercise rehabilitation training during the vulnerable period in patients with ADHF significantly increased the 6-min walk test distance (6-MWTD) (SMD = 0.37; 95 %CI: 0.09, 0.65; P = 0.01), short physical performance battery (SPPB) score (MD = 1.26; 95 %CI: 0.82, 1.70; P < 0.001) and peak oxygen consumption (VO2peak) (SMD = 1.43; 95 %CI: 0.53, 2.34; P = 0.002), improved quality of life (QoL) (SMD = 0.85; 95 %CI: 0.07, 1.64, P = 0.03), reduced depression score (MD = -0.73; 95 %CI: 1.27, -0.18; P = 0.009), frailty (MD = -0.22; 95 %CI: -0.48, 0.05; P = 0.11), and decreased 6-month all-cause readmission (OR = 0.67; 95 %CI: 0.49, 0.91; P = 0.01). However, no statistically significant differences were observed between the two groups in left ventricular ejection fraction (LVEF) (MD = 0.96; 95 %CI: -1.84, 3.77; P = 0.50), 6-month heart failure (HF)-related readmission (OR = 1.01; 95 %CI: 0.66, 1.53; P = 0.98), and all-cause mortality (OR = 0.63; 95 %CI: 0.18, 2.24; P = 0.47). There were no adverse events reported.

Conclusions: Exercise rehabilitation during the vulnerable phase improves exercise tolerance, QoL, and depressive symptoms while reducing 6-month all-cause readmissions in ADHF patients, with no reported adverse events. Although trends toward improved LVEF, HF-related readmissions, and all-cause mortality were observed. Large-scale, high-quality studies are warranted to explore individualized responses and long-term outcomes.

Keywords: Acute decompensated heart failure; Evidence-based nursing; Exercise rehabilitation; Meta-analysis; Vulnerable period.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Flow chart of the study selection process. AHA = American Heart Association. ESC = European Society of Cardiology.
Fig. 2
Fig. 2
Bias risk assessment of the included studies.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Tang T.T., Liao Y.H. Interpret the 2023 fupdate of the 2021 ESC guidelines for diagnosing and treating acute and chronic heart failure. J Clin Cardiol. 2023;39(10):749–752. doi: 10.13201/j.issn.1001-1439.2023.10.003. - DOI
    1. Chen X.Y., Zhang F.Y. Progress in the definition and management of the vulnerable phase after hospitalization for heart failure. Chin Heart J. 2022;34(3):348–351.
    1. Serrano J.A.M., López J.A.C., Mendoza A.C., Ivey-Miranda J.B., Zavala G.H.M., Domínguez L.O., et al. Vulnerable period in heart failure: a window of opportunity for the optimization of treatment - a statement by Mexican experts. Drugs Context. 2024;13:2023–2028. doi: 10.7573/dic.2023-8-1. 1. - DOI - PMC - PubMed
    1. Emmons-Bell S., Johnson C., Roth G. Prevalence, incidence and survival of heart failure: a systematic review. Heart. 2022;108(17):1351–1360. doi: 10.1136/heartjnl-2021-320131. - DOI - PMC - PubMed
    1. Taylor R.S., Walker S., Smart N.A., Piepoli M.F., Warren F.C., Ciani O., et al. Impact of exercise rehabilitation on exercise capacity and quality-of-life in heart failure: individual participant meta-analysis. J Am Coll Cardiol. 2019;73(12):1430–1443. doi: 10.1016/j.jacc.2018.12.072. - DOI - PMC - PubMed

LinkOut - more resources